Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-2.01%)
Close on Nov 17, 2026Market cap $457.03KP/E –Yield –
Arcadia Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Arcadia Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -234.5%. For fiscal 2025 it was -48.1%, against -139.5% the year before. The highest annual figure on record is -48.1% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -48.1% | +91.4 |
| FY2024 | Dec 31, 2024 | -139.5% | +174.4 |
| FY2023 | Dec 31, 2023 | -313.9% | −106.6 |
| FY2022 | Dec 31, 2022 | -207.3% | +8.9 |
| FY2021 | Dec 31, 2021 | -216.2% | −158.3 |
| FY2020 | Dec 31, 2020 | -57.9% | +2406.1 |
| FY2019 | Dec 31, 2019 | -2464.1% | −1543.3 |
| FY2018 | Dec 31, 2018 | -920.8% | −530.6 |
| FY2017 | Dec 31, 2017 | -390.1% | +225.4 |
| FY2016 | Dec 31, 2016 | -615.6% | −283.9 |
| FY2015 | Dec 31, 2015 | -331.7% | −69.0 |
| FY2014 | Dec 31, 2014 | -262.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -434.2% | −127.8 |
| Q1 FY2026 | Mar 31, 2026 | -398.6% | −615.2 |
| Q4 FY2025 | Dec 31, 2025 | -148.3% | +185.9 |
| Q3 FY2025 | Sep 30, 2025 | 65.7% | +170.6 |
| Q2 FY2025 | Jun 30, 2025 | -306.4% | −387.6 |
| Q1 FY2025 | Mar 31, 2025 | 216.6% | +462.1 |
| Q4 FY2024 | Dec 31, 2024 | -334.2% | +33.0 |
| Q3 FY2024 | Sep 30, 2024 | -104.9% | +92.9 |
| Q2 FY2024 | Jun 30, 2024 | 81.2% | +17.8 |
| Q1 FY2024 | Mar 31, 2024 | -245.5% | +516.2 |
| Q4 FY2023 | Dec 31, 2023 | -367.2% | +203.2 |
| Q3 FY2023 | Sep 30, 2023 | -197.8% | −15.2 |
| Q2 FY2023 | Jun 30, 2023 | 63.5% | +161.4 |
| Q1 FY2023 | Mar 31, 2023 | -761.7% | −622.3 |
| Q4 FY2022 | Dec 31, 2022 | -570.4% | −142.9 |
| Q3 FY2022 | Sep 30, 2022 | -182.6% | −91.1 |
| Q2 FY2022 | Jun 30, 2022 | -97.9% | +276.5 |
| Q1 FY2022 | Mar 31, 2022 | -139.4% | −387.9 |
| Q4 FY2021 | Dec 31, 2021 | -427.5% | −552.3 |
| Q3 FY2021 | Sep 30, 2021 | -91.5% | +1943.8 |
| Q2 FY2021 | Jun 30, 2021 | -374.4% | +3073.6 |
| Q1 FY2021 | Mar 31, 2021 | 248.6% | −568.6 |
| Q4 FY2020 | Dec 31, 2020 | 124.8% | +1625.5 |
| Q3 FY2020 | Sep 30, 2020 | -2035.4% | +1583.8 |
| Q2 FY2020 | Jun 30, 2020 | -3448.0% | −5535.2 |
| Q1 FY2020 | Mar 31, 2020 | 817.2% | +8799.4 |
| Q4 FY2019 | Dec 31, 2019 | -1500.7% | −1355.2 |
| Q3 FY2019 | Sep 30, 2019 | -3619.1% | −4821.8 |
| Q2 FY2019 | Jun 30, 2019 | 2087.2% | +3616.8 |
| Q1 FY2019 | Mar 31, 2019 | -7982.3% | −3022.0 |
| Q4 FY2018 | Dec 31, 2018 | -145.5% | +61.8 |
| Q3 FY2018 | Sep 30, 2018 | 1202.7% | +1971.0 |
| Q2 FY2018 | Jun 30, 2018 | -1529.6% | −1125.3 |
| Q1 FY2018 | Mar 31, 2018 | -4960.3% | −4546.1 |
| Q4 FY2017 | Dec 31, 2017 | -207.3% | +849.8 |
| Q3 FY2017 | Sep 30, 2017 | -768.3% | −379.9 |
| Q2 FY2017 | Jun 30, 2017 | -404.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -414.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -1057.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -388.4% | – |
See a number that looks wrong?